"A randomized, placebo-controlled, phase 2 study of the efficacy and safety of droxidopa in patients with intradialytic hypotension" by Mark D Vannorsdall

Selected Works of Srinivas Hariachar, MD

Article

A randomized, placebo-controlled, phase 2 study of the efficacy and safety of droxidopa in patients with intradialytic hypotension

Postgraduate Medicine (2015)

Mark D Vannorsdall, Eastern Nephrology CMTG , Greenville, NC , USA.
Srinivas Hariachar, Outcomes Research International, Inc, Hudson, FL, USA
L Arthur Hewitt, Lundbeck

Link

Disciplines

Medicine and Health Sciences,
Anesthesiology and
Surgery

Publication Date

February 24, 2015

DOI

10.1080/00325481.2015.1015393

Citation Information

Mark D Vannorsdall, Srinivas Hariachar and L Arthur Hewitt. "A randomized, placebo-controlled, phase 2 study of the efficacy and safety of droxidopa in patients with intradialytic hypotension" Postgraduate Medicine Vol. 127 Iss. 2 (2015) p. 133 - 143
Available at: http://works.bepress.com/srinivas-hariachar/1/